Literature DB >> 2140441

Biological effects of adrenal androgens on MCF-7 and BT-20 human breast cancer cells.

A Najid1, G Habrioux.   

Abstract

The MCF-7 human breast cancer cell line responds to 5-androstene-3 beta,17 beta-diol, to dehydroepiandrosterone and to its 3 beta-sulfate stimulation in vitro by increased proliferation. 5-Androstene-3 beta,17 beta-diol has the strongest mitogenic effect. Dehydroepiandrosterone has a more potent action on cell proliferation than its 3 beta-sulfate. These adrenal androgens do not stimulate proliferation of the estrogen receptors negative for the BT-20 cell line. In our conditions, we have failed to demonstrate MCF-7 estradiol formation when incubations were carried out in the presence of labeled adrenal androgens. These results suggest that adrenal androgens stimulate proliferation of MCF-7 cells directly by acting on estrogen receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2140441     DOI: 10.1159/000226830

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  4 in total

1.  Dehydroepiandrosterone concentration in breast cancer tissue is related to its plasma gradient across the mammary gland.

Authors:  E Brignardello; P Cassoni; M Migliardi; A Pizzini; M Di Monaco; G Boccuzzi; M Massobrio
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

2.  Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells.

Authors:  M Di Monaco; A Pizzini; V Gatto; L Leonardi; M Gallo; E Brignardello; G Boccuzzi
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol.

Authors:  G Boccuzzi; E Brignardello; M Di Monaco; V Gatto; L Leonardi; A Pizzini; M Gallo
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

4.  Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer.

Authors:  Elisabetta Pietri; Ilaria Massa; Sara Bravaccini; Sara Ravaioli; Maria Maddalena Tumedei; Elisabetta Petracci; Caterina Donati; Alessio Schirone; Federico Piacentini; Lorenzo Gianni; Mario Nicolini; Enrico Campadelli; Alessandra Gennari; Alessandro Saba; Beatrice Campi; Linda Valmorri; Daniele Andreis; Francesco Fabbri; Dino Amadori; Andrea Rocca
Journal:  Oncologist       Date:  2018-12-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.